CN113945647A - Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide - Google Patents

Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide Download PDF

Info

Publication number
CN113945647A
CN113945647A CN202010687909.4A CN202010687909A CN113945647A CN 113945647 A CN113945647 A CN 113945647A CN 202010687909 A CN202010687909 A CN 202010687909A CN 113945647 A CN113945647 A CN 113945647A
Authority
CN
China
Prior art keywords
temperature
isopropanol
ethanol
headspace
valsartan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010687909.4A
Other languages
Chinese (zh)
Inventor
张贵民
房兆营
杨昆昊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lunan Pharmaceutical Group Corp
Original Assignee
Lunan Pharmaceutical Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunan Pharmaceutical Group Corp filed Critical Lunan Pharmaceutical Group Corp
Priority to CN202010687909.4A priority Critical patent/CN113945647A/en
Publication of CN113945647A publication Critical patent/CN113945647A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/30Control of physical parameters of the fluid carrier of temperature

Abstract

The invention belongs to the field of pharmaceutical analysis, and relates to a method for simultaneously detecting ethanol and isopropanol in a valsartan hydrochlorothiazide preparation. The detection method can effectively detect the content of ethanol and isopropanol in the valsartan hydrochlorothiazide, and has the advantages of high sensitivity, high separation degree, good repeatability and durability, simple operation and stable and reliable result, thereby being used for controlling the ethanol and the isopropanol in the valsartan hydrochlorothiazide and providing effective guarantee for the quality of final finished products.

Description

Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide
Technical Field
The invention relates to a method for detecting solvent residues in a valsartan and hydrochlorothiazide raw material and a preparation, in particular to a method for detecting ethanol and isopropanol in the valsartan and hydrochlorothiazide raw material and the preparation by using a gas chromatography, belonging to the field of pharmaceutical analysis.
Background
Valsartan is an angiotensin II receptor antagonist antihypertensive drug, can be used for various types of hypertension, has a good protective effect on heart, brain and kidney, does not affect the bradykinin level in vivo after administration, stably reduces blood pressure, does not affect cardiac rhythm, has few side effects, has good safety and tolerance, and belongs to one of five classic antihypertensive drugs. The composition has the advantages of being capable of achieving more obvious curative effect when being used together with hydrochlorothiazide, reducing blood pressure of patients, being beneficial to preventing left ventricular remodeling and reducing proteinuria, being a very advantageous composition in clinic at present, being capable of avoiding hyperkalemia caused by valsartan and hypokalemia caused by hydrochlorothiazide, being capable of avoiding adverse reactions to a great extent, and being a first-line clinical medicine. In the production process, the valsartan and hydrochlorothiazide tablets/capsules/dispersion tablets use organic solvents of ethanol and isopropanol, the valsartan structure contains carboxyl, and after the valsartan and the isopropanol contact with the ethanol and the isopropanol, the valsartan and the hydrochlorothiazide tablets react to generate valsartan ethyl ester and valsartan isopropyl ester, so that the content of related substances in a valsartan raw material and a preparation of the valsartan raw material is increased. Therefore, the content of ethanol and isopropanol needs to be strictly controlled in the production process.
CN111060628A discloses a method for detecting residual solvent, which can continuously detect the residual amount of 7 mailing solvents of acetonitrile, toluene, methanol, ethanol, acetone, ethyl acetate, and isopropanol, but the method is only used for detecting tacrolimus drugs, and is not suitable for valsartan hydrochlorothiazide.
CN103698424B discloses a method for detecting ethanol and isopropanol residues, but is applicable to insoluble aluminum salt drugs and also not applicable to valsartan hydrochlorothiazide.
In view of the fact that excessive organic solvent residues are harmful to human bodies, and the international harmonization conference (ICH) guidelines are limited to ethanol and isopropanol in the national pharmacopoeia 2015 edition and the technical requirements for registration of human drugs, the residual amounts of ethanol and isopropanol in valsartan hydrochlorothiazide are not controlled in the current standard, and therefore a method for detecting the contents of ethanol and isopropanol must be established.
Disclosure of Invention
The method can simultaneously detect the ethanol and the isopropanol in the valsartan hydrochlorothiazide by adopting the gas chromatography, and can be used for quality control in production. The method has the characteristics of high sensitivity and good peak shape, the analysis method is stable, and the detection limit of ethanol and isopropanol is low.
In order to achieve the purpose of the invention, the inventor finally obtains the following technical scheme through a large number of experiments:
the method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide by using gas chromatography comprises the following steps:
a chromatographic column: the stationary phase is a chromatographic column of polyethylene glycol;
initial column temperature: 35-55 ℃;
a detector: hydrogen flame ionization, the detector temperature is 180-280 ℃;
carrier gas: nitrogen, flow rate: 1-5 ml/min;
headspace sample introduction: the head space temperature is 60-120 ℃, and the head space time is 20-60 min;
the valsartan and hydrochlorothiazide preparation is valsartan and hydrochlorothiazide bulk drug, tablet, dispersible tablet or capsule.
The temperature rising procedure is as follows:
Figure BDA0002588255490000021
specifically, the gas chromatography method of the invention comprises the following steps:
initial column temperature: 45 ℃;
the carrier gas is nitrogen;
the chromatographic column is a chromatographic column with a fixed phase of polyethylene glycol;
the temperature of the detector is 280 ℃;
the temperature of a sample inlet is 200 ℃;
the headspace temperature was 100 ℃ and the headspace time was 30 min;
the flow rate is 3.0 mL/min;
the temperature rising procedure is as follows:
Figure BDA0002588255490000022
Figure BDA0002588255490000031
the invention relates to a method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide by using gas chromatography, which comprises the following specific operation steps:
a. dissolving appropriate amount of ethanol reference substance in water to obtain reference substance solution containing 0.5mg ethanol per 1ml, placing 2ml in 20ml headspace bottle, and sealing to obtain reference substance solution;
b. dissolving appropriate amount of isopropanol reference substance in water to obtain reference substance solution containing 0.5mg ethanol per 1ml, placing 2ml in 20ml headspace bottle, and sealing to obtain reference substance solution;
c. taking a proper amount of valsartan hydrochlorothiazide, placing the valsartan hydrochlorothiazide in a 20ml headspace bottle, adding 2ml of water, and sealing to obtain a test solution;
d. respectively taking headspace samples of a reference substance and a test solution, and completing analysis and detection of ethanol and isopropanol in the valsartan hydrochlorothiazide according to the following chromatographic conditions;
chromatographic conditions are as follows:
a chromatographic column: the stationary phase is a chromatographic column of polyethylene glycol;
initial column temperature: 35-55 ℃;
a detector: hydrogen flame ionization, the detector temperature is 180-280 ℃;
carrier gas: nitrogen, flow rate: 1-5 ml/min;
headspace sample introduction: the head space temperature is 60-120 ℃, and the head space time is 20-60 min;
the temperature rising procedure is as follows:
Figure BDA0002588255490000032
the analysis method provided by the invention can effectively detect the content of ethanol and isopropanol in the valsartan hydrochlorothiazide, and the method has the advantages of high separation degree, good repeatability and durability, low detection limit, simple operation and stable and reliable result, so that the method can be used for quality control of valsartan raw materials and preparations thereof, and provides effective guarantee for the quality of final finished products.
Drawings
FIG. 1 GC spectrum of blank solvent
FIG. 2 GC spectrum of blank auxiliary materials
FIG. 3 GC spectrum of ethanol peak location
FIG. 4 GC spectra of isopropanol peak localization
FIG. 5 GC-Spectroscopy of ethanol and isopropanol control solutions of example 1
FIG. 6 GC-map of valsartan raw material test sample solution in example 1
FIG. 7 GC spectrum of sample solution of example 1 hydrochlorothiazide
FIG. 8 GC spectrum of test solution of valsartan hydrochlorothiazide tablet in example 1
Detailed Description
The following are specific examples of the present invention and further describe the technical solutions of the present invention, but the scope of the present invention is not limited to these examples. All changes, modifications and equivalents that do not depart from the spirit of the invention are intended to be included within the scope thereof.
First, research and evaluation of ethanol and isopropanol checking methodology
1. Instruments and conditions: shimadzu chromatography system, hydrogen flame ionization detector, column: TRACE TR-WAX (30 m.times.0.32 mm, 0.25 μm); detector temperature: 280 ℃; sample inlet temperature: 200 ℃; taking nitrogen as carrier gas; the flow rate is 3 ml/min; introducing a sample in a headspace, wherein the headspace temperature is 100 ℃, and the headspace time is 30 min; initial column temperature: at 45 ℃.
The temperature programmed elution was set as:
Figure BDA0002588255490000041
2. the test steps are as follows:
2.1 specificity
1) Blank solvent interference test
Placing 2ml water in 20ml headspace bottle, sealing, determining according to the above chromatographic conditions, and recording chromatogram, wherein GC chromatogram is shown in figure 1.
As can be seen from the attached figure 1, the blank solvent has no interference with the impurity peaks detected by ethanol and isopropanol.
2) Interference test of auxiliary materials
Taking about 200mg of valsartan and hydrochlorothiazide tablet auxiliary materials, placing the valsartan and hydrochlorothiazide tablet auxiliary materials into a 20ml headspace bottle, adding 2ml of water, sealing, determining according to the chromatographic conditions, recording a chromatogram, wherein a GC (gas chromatography) spectrum is shown in an attached figure 2. As can be seen from the attached figure 2, the auxiliary materials do not interfere with the impurity peaks detected by ethanol and isopropanol.
3) Peak location test for ethanol
Dissolving appropriate amount of ethanol reference substance in water to obtain reference substance solution containing 0.5mg ethanol per 1ml, placing 2ml in 20ml headspace bottle, sealing, measuring according to the above chromatographic conditions, recording chromatogram, and showing HPLC chromatogram in figure 3. As can be seen from FIG. 3, the retention time of ethanol was 5.153 min.
4) Isopropanol peak location test
Dissolving appropriate amount of isopropanol reference substance in water to obtain reference substance solution containing isopropanol 0.5mg per 1ml, placing 2ml in 20ml headspace bottle, sealing, measuring according to the above chromatographic conditions, and recording chromatogram, wherein HPLC chromatogram is shown in figure 4. As can be seen from FIG. 4, the retention time of isopropanol is 6.355 min.
2.2 limit of quantitation and detection
1) And (4) quantitative limit: taking a proper amount of ethanol reference substance, preparing a solution of 3.11 μ g/ml with water as a limit solution, and determining according to the method, wherein the retention time of ethanol is 5.100min and the S/N is 12 according to the chromatogram map.
Taking a proper amount of isopropanol as a reference substance, preparing a solution of 2.98. mu.g/ml with water, and determining according to the method, wherein the retention time of ethanol is 6.350min and the S/N is 13 according to the chromatogram map.
2) Detection limit: taking appropriate amount of ethanol control, preparing 1.50 μ g/ml solution with water, and determining according to the method, wherein the retention time of ethanol is 5.113min and S/N is 4.
Taking a proper amount of isopropanol as a reference substance, preparing a solution with the concentration of 1.47 mu g/ml with water, and determining according to the method by using the detection limit solution, wherein the retention time of the isopropanol is 6.333min and the S/N is 3 according to a chromatogram map.
2.3 Linearity and Range
Taking a proper amount of ethanol reference substances, preparing solutions with the series concentrations of 47.7 mu g/ml, 95.4 mu g/ml, 190.9 mu g/ml, 286.3 mu g/ml, 477.2 mu g/ml, 763.5 mu g/ml and 954.3 mu g/ml by using water, injecting the solutions respectively, measuring according to the chromatographic conditions, recording a chromatogram map, and obtaining a linear equation.
TABLE 1 ethanol Peak area and concentration Curve Table
Figure BDA0002588255490000051
Figure BDA0002588255490000061
As is clear from Table 1, the linear relationship between the concentration and the peak area was good in the range of 47.7 to 954.3. mu.g/ml for ethanol.
Taking a proper amount of isopropanol reference substances, preparing solutions with series concentrations of 49.8 mu g/ml, 99.7 mu g/ml, 199.4 mu g/ml, 299.1 mu g/ml, 498.5 mu g/ml, 797.6 mu g/ml and 997.0 mu g/ml by using water, injecting samples respectively, measuring according to the chromatographic conditions, and recording a chromatogram map to obtain a linear equation.
TABLE 2 isopropyl alcohol peak area versus concentration curve table
Figure BDA0002588255490000062
As can be seen from Table 2, the isopropanol concentration was in the range of 49.8 to 997.0. mu.g/ml, and the linear relationship between the concentration and the peak area was good.
2.4 durability test
1) Instruments and conditions: shimadzu chromatography system, hydrogen flame ionization detector, column: TRACE TR-WAX (30 m.times.0.32 mm, 0.25 μm); detector temperature: 280 ℃; sample inlet temperature: 200 ℃; taking nitrogen as carrier gas; the flow rate is 3 ml/min; introducing a sample in a headspace, wherein the headspace temperature is 100 ℃, and the headspace time is 30 min; initial column temperature: at 45 ℃.
The temperature programmed elution was set as:
Figure BDA0002588255490000063
and (3) determination: respectively taking appropriate amount of ethanol and isopropanol as reference substances, dissolving in water to obtain reference substance solution containing ethanol and isopropanol 0.5mg each per 1ml, placing 2ml in 20ml headspace bottle, sealing, determining according to the above chromatographic conditions, and recording chromatogram.
Under the condition, the retention time of the ethanol is 5.117min, the retention time of the isopropanol is 6.341min, and impurity peaks of the ethanol and the isopropanol are not interfered.
2) Instruments and conditions: shimadzu chromatography system, hydrogen flame ionization detector, column: TRACE TR-WAX (30 m.times.0.32 mm, 0.25 μm); detector temperature: 280 ℃; sample inlet temperature: 200 ℃; taking nitrogen as carrier gas; the flow rate is 3 ml/min; introducing a sample in a headspace, wherein the headspace temperature is 100 ℃, and the headspace time is 30 min; initial column temperature: at 55 ℃.
The temperature programmed elution was set as:
Figure BDA0002588255490000071
and (3) determination: respectively taking appropriate amount of ethanol and isopropanol as reference substances, dissolving in water to obtain reference substance solution containing ethanol and isopropanol 0.5mg each per 1ml, placing 2ml in 20ml headspace bottle, sealing, determining according to the above chromatographic conditions, and recording chromatogram.
Under the condition, the retention time of the ethanol is 4.537min, the retention time of the isopropanol is 5.842min, and impurity peaks of the ethanol and the isopropanol are not interfered.
3) Instruments and conditions: shimadzu chromatography system, hydrogen flame ionization detector, column: TRACE TR-WAX (30 m.times.0.32 mm, 0.25 μm); detector temperature: 280 ℃; sample inlet temperature: 200 ℃; taking nitrogen as carrier gas; the flow rate is 3 ml/min; introducing a sample in a headspace, wherein the headspace temperature is 100 ℃, and the headspace time is 30 min; initial column temperature: 35 ℃ is carried out.
The temperature programmed elution was set as:
Figure BDA0002588255490000072
and (3) determination: respectively taking appropriate amount of ethanol and isopropanol as reference substances, dissolving in water to obtain reference substance solution containing ethanol and isopropanol 0.5mg each per 1ml, placing 2ml in 20ml headspace bottle, sealing, determining according to the above chromatographic conditions, and recording chromatogram.
Under the condition, the retention time of the ethanol is 6.432min, the retention time of the isopropanol is 7.366min, and impurity peaks of the ethanol and the isopropanol are not interfered.
4) Instruments and conditions: shimadzu chromatography system, hydrogen flame ionization detector, column: TRACE TR-WAX (30 m.times.0.32 mm, 0.25 μm); detector temperature: 280 ℃; sample inlet temperature: 200 ℃; taking nitrogen as carrier gas; the flow rate is 1 ml/min; introducing a sample in a headspace, wherein the headspace temperature is 100 ℃, and the headspace time is 30 min; initial column temperature: at 45 ℃.
The temperature programmed elution was set as:
Figure BDA0002588255490000081
and (3) determination: respectively taking appropriate amount of ethanol and isopropanol as reference substances, dissolving in water to obtain reference substance solution containing ethanol and isopropanol 0.5mg each per 1ml, placing 2ml in 20ml headspace bottle, sealing, determining according to the above chromatographic conditions, and recording chromatogram.
Under the condition, the retention time of the ethanol is 6.177min, the retention time of the isopropanol is 7.140min, and impurity peaks of the ethanol and the isopropanol are not interfered.
5) Instruments and conditions: shimadzu chromatography system, hydrogen flame ionization detector, column: TRACE TR-WAX (30 m.times.0.32 mm, 0.25 μm); detector temperature: 280 ℃; sample inlet temperature: 200 ℃; taking nitrogen as carrier gas; the flow rate is 5 ml/min; introducing a sample in a headspace, wherein the headspace temperature is 100 ℃, and the headspace time is 30 min; initial column temperature: at 45 ℃.
The temperature programmed elution was set as:
Figure BDA0002588255490000082
and (3) determination: respectively taking appropriate amount of ethanol and isopropanol as reference substances, dissolving in water to obtain reference substance solution containing ethanol and isopropanol 0.5mg each per 1ml, placing 2ml in 20ml headspace bottle, sealing, determining according to the above chromatographic conditions, and recording chromatogram.
Under the condition, the retention time of the ethanol is 4.260min, the retention time of the isopropanol is 5.107min, and impurity peaks of the ethanol and the isopropanol are not interfered.
Example 1
Instruments and conditions: shimadzu chromatography system, hydrogen flame ionization detector, column: TRACE TR-WAX (30 m.times.0.32 mm, 0.25 μm); detector temperature: 280 ℃; sample inlet temperature: 200 ℃; taking nitrogen as carrier gas; the flow rate is 3 ml/min; introducing a sample in a headspace, wherein the headspace temperature is 100 ℃, and the headspace time is 30 min; initial column temperature: at 45 ℃.
The temperature programmed elution was set as:
Figure BDA0002588255490000091
and (3) determination: respectively taking appropriate amount of ethanol and isopropanol as reference substances, dissolving in water to obtain reference substance solution containing ethanol and isopropanol 0.5mg each per 1ml, placing 2ml in 20ml headspace bottle, sealing, determining according to the above chromatographic conditions, and recording chromatogram. The GC spectrum is shown in FIG. 5.
As can be seen from fig. 5: the retention time of the ethanol is 5.165min, the retention time of the isopropanol is 6.357min, and impurity peaks of the ethanol and the isopropanol are not interfered.
2. Valsartan starting material
Taking about 200mg of valsartan raw material, placing the valsartan raw material in a 20ml headspace bottle, adding 2ml of water, sealing, determining according to the chromatographic conditions, and recording a chromatogram, wherein a GC (gas chromatography) spectrum is shown in figure 6.
As can be seen from figure 6, the valsartan starting material does not interfere with the impurity peaks detected by ethanol and isopropanol.
3. Hydrochlorothiazide feedstock
Taking about 200mg of hydrochlorothiazide as a raw material, placing the hydrochlorothiazide into a 20ml headspace bottle, adding 2ml of water, sealing, measuring according to the chromatographic conditions, and recording a chromatogram, wherein a GC (gas chromatography) spectrum is shown in figure 7.
As can be seen from fig. 7, the hydrochlorothiazide feed material has impurity peaks that interfere with the detection of ethanol and isopropanol.
4. Valsartan hydrochlorothiazide tablet
Taking about 200mg of valsartan and hydrochlorothiazide tablets, putting the valsartan and hydrochlorothiazide tablets into a 20ml headspace bottle, adding 2ml of water, sealing, determining according to the chromatographic conditions, recording a chromatogram, wherein the GC spectrum is shown in figure 8.
As shown in the attached figure 8, the valsartan hydrochlorothiazide tablet contains trace ethanol and isopropanol, the retention time is 5.152min and 6.346min respectively, and impurity peaks detected by the ethanol and the isopropanol are not interfered.
From the above test results, it can be seen that: the detection method can effectively detect the content of ethanol in the valsartan raw material and the preparation thereof, and the blank auxiliary materials and the blank solvent have no interference on the ethanol in the valsartan raw material and the preparation thereof, so the method can be used for quality control of the valsartan raw material and the preparation thereof.

Claims (9)

1. A method for simultaneously detecting ethanol and isopropanol in valsartan hydrochlorothiazide is characterized in that: the method is gas chromatography detection, adopts a headspace sample injection mode, adopts nitrogen as carrier gas, adopts a chromatographic column with a fixed phase of polyethylene glycol, adopts a hydrogen flame ionization detector as the type of the detector, and performs temperature programming.
2. The method of claim 1, wherein the valsartan hydrochlorothiazide formulation is a valsartan hydrochlorothiazide drug substance, tablet, dispersible tablet or capsule.
3. The method of claim 1, wherein the temperature ramp program is:
Figure FDA0002588255480000011
4. the method according to claim 1, wherein the headspace sampling temperature is 60 ℃ to 120 ℃ and the headspace time is 20min to 60min, preferably the headspace temperature is 100 ℃ and the headspace time is 30 min.
5. The method of claim 1, wherein the carrier gas is nitrogen at a flow rate of 1 to 5ml/min, preferably at a flow rate of 3 ml/min.
6. The method of claim 1, wherein the detector is a hydrogen flame ionization detector and the detector temperature is 180 ℃ to 280 ℃, preferably 280 ℃.
7. The method of claim 1, wherein the chromatographic column has a stationary phase of polyethylene glycol, the initial column temperature: 35-55 ℃.
8. The method according to claim 1, wherein the injection port temperature is 150 ℃ to 280 ℃, preferably 200 ℃.
9. The method of any one of claims 1-8, wherein the gas chromatography is:
initial column temperature: 45 ℃;
the carrier gas is nitrogen;
the chromatographic column is a chromatographic column with a fixed phase of polyethylene glycol;
the temperature of the detector is 280 ℃;
the temperature of a sample inlet is 200 ℃;
the headspace temperature was 100 ℃ and the headspace time was 30 min;
the flow rate is 3.0 mL/min;
the temperature rising procedure is as follows:
Figure FDA0002588255480000021
CN202010687909.4A 2020-07-16 2020-07-16 Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide Pending CN113945647A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010687909.4A CN113945647A (en) 2020-07-16 2020-07-16 Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010687909.4A CN113945647A (en) 2020-07-16 2020-07-16 Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide

Publications (1)

Publication Number Publication Date
CN113945647A true CN113945647A (en) 2022-01-18

Family

ID=79326475

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010687909.4A Pending CN113945647A (en) 2020-07-16 2020-07-16 Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide

Country Status (1)

Country Link
CN (1) CN113945647A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130316388A1 (en) * 2012-05-25 2013-11-28 Health Diagnostic Laboratory, Inc. Process and apparatus for rapid, high-throughput analysis of fatty acids
CN108445110A (en) * 2018-05-03 2018-08-24 四川科伦药业股份有限公司 The detection method of residual solvent in a kind of semi-synthetic fish oil bulk pharmaceutical chemicals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130316388A1 (en) * 2012-05-25 2013-11-28 Health Diagnostic Laboratory, Inc. Process and apparatus for rapid, high-throughput analysis of fatty acids
CN108445110A (en) * 2018-05-03 2018-08-24 四川科伦药业股份有限公司 The detection method of residual solvent in a kind of semi-synthetic fish oil bulk pharmaceutical chemicals

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
李会轻等: "顶空气相色谱法测定盐酸拉贝洛尔中有机溶剂残留量", 《中国药事》 *
黄宁华等: "顶空毛细管气相色谱法测定盐酸 拉贝洛尔中有机残留量", 《实验技术与管理》 *
黄祝刚等: "顶空- 气相色谱法测定葡萄糖氯化钠 注射液中 12 种溶剂残留量", 《化学分析计量》 *

Similar Documents

Publication Publication Date Title
Zhang et al. Characterization and quantification of major constituents of Xue Fu Zhu Yu by UPLC-DAD–MS/MS
Kim et al. Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry
CN111766312A (en) Method for detecting antifungal drugs in serum by ultra-high performance liquid chromatography tandem mass spectrometry technology
Zeng et al. An automated dual-gradient liquid chromatography–MS/MS method for the simultaneous determination of ferulic acid, ligustrazine and ligustilide in rat plasma and its application to a pharmacokinetic study
CN103076409B (en) Analysis and detection method for oxiracetam and impurities thereof
CN110031568B (en) Method for determining concentration of Sacubitril, desethylSacubitril and valsartan in human plasma
CN113009060A (en) Method for measuring content of oxycodone hydrochloride by high performance liquid chromatography
Brondi et al. Development and validation of a chromatography method using tandem UV/charged aerosol detector for simultaneous determination of amlodipine besylate and olmesartan medoxomil: application to drug-excipient compatibility study
CN110208440B (en) Method for detecting residual quantity of ethanol in amoxicillin and clavulanate potassium preparation
Wen et al. A sensitive liquid chromatography–electrospray ionization–mass spectrometry method for the simultaneous determination of pentoxyverine citrate and guaifenesin in human plasma—application to pharmacokinetic and bioequivalence studies
CN112946099B (en) Method for detecting related substances in amino acid glucose injection
CN113945647A (en) Method for detecting ethanol and isopropanol in valsartan hydrochlorothiazide
CN101603954A (en) The anti-depressant determination method by liquid chromatography-electrospray mass of β-class
Abu-Nameh et al. High-performance liquid chromatographic determination of simvastatin in medical drugs
Chen et al. Liquid chromatography–mass spectrometry analysis of macranthoidin B, macranthoidin A, dipsacoside B, and macranthoside B in rat plasma for the pharmacokinetic investigation
CN112710766A (en) Method and kit for detecting five immunosuppressive agents in dried blood tablets
CN102662022A (en) Pharmacokinetics measurement method for oral bulleyaconitine A tablets of rat
Aljohani et al. Development and validation of a HPLC-UV method for dissolution testing of ciclosporin: its application to the measurement of brand and generic versions from different countries
CN113945646A (en) Method for detecting ethanol in valsartan
CN109270178B (en) Method for separating and measuring dutasteride and related substances in dutasteride soft capsules by high performance liquid chromatography
Wang et al. Determination of anlotinib, a tyrosine kinase inhibitor, in rat plasma by UHPLC-MS/MS and its application to a pharmacokinetic study
Jia et al. Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by liquid chromatography–isotope dilution tandem mass spectrometry method
CN109187832B (en) Method for determining phenylephrine concentration by LC-MS/MS (liquid chromatography-mass spectrometry/mass spectrometry) and sample pretreatment method
CN112666278A (en) Limit detection method for strychnine in Huatuo reconstruction pills
Qin et al. Determination of bergenin in rat plasma by high-performance liquid chromatography

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination